Camilo E. Fadul MD

Contact Information:

Phone: (603) 650-6312

Fax: (603) 653-0610

Email: not given

Institution Affiliations:

Professor of Medicine (Hematology/Oncology)

Department of: MEDICINE

Section: Hematology/Oncology

Specialty: Neurology

Joined Staff: 1995

Cancer Center Membership:

Neuro-Oncology Program

Immunology and Cancer Immunotherapy Research Program

Clinical Interests:

Primary Brain Tumors

Multiple Sclerosis

Neurologic Complications of Systemic Cancer

Board Certified:

Neurology

Neurology 1996

Degree(s): MD

School of Medicine, Universidad del Rosario, Bogota, Colombia 1980

Internship(s):

Residency:

Hospital Militar Central, Universidad del Rosario, Bogota, Colombia, (Rotating) 1979-80

Hospital Militar Central, Universidad del Rosario, Bogota, Colombia, (Neurology) 1981-84

Dartmouth-Hitchcock Medical Center, Lebanon, NH, (Neurology) , Chief Resident, 1993-94 1992-94

Fellowship(s):

Vanderbilt University School of Medicine, Nashville, TN, (Neurology) 1984-85

Cornell University Medical Ctr./Memorial Sloan-Kettering Cancer Ctr., New York, NY, (Neurologic Oncology) 1985-87

Biography:

Dr. Fadul received his MD from the Universidad el Rosario in Bogota, Colombia in 1979. In 1984 he completed his residency in neurology from the Hospital Militar Central, Bogota, Colombia. Dr. Fadul was a Neurologic Oncology Fellow at Memorial Sloan Kettering from 1985 - 1987, and then he came to DHMC to complete a US Neurology residency in 1994. Dr. Fadul joined the staff of the Dartmouth Medical School in 1994 as an Assistant Research Professor of Medicine. In 1995 his status changed to that of Assistant Clinical Professor of Medicine. In 2001 his status changed again, to that of Associate Professor of Medicine.

Research Interests:

Dr. Fadul's clinical research areas are in primary brain tumors, neurologic complications of cancer, immunotherapy, and medical education.

Selected Publications:

Fadul CE, Wen PY, Kim L, et al. Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme. J Neurooncol 2008; 89:339-357.

Fadul CE, Kingman LS, Meyer LP, Cole BF, Eskey CJ, Rhodes CH, Roberts DW, Newton HB, Pipas JM. A Phase II Study of Thalidomide and Irinotecan for Treatment of Glioblastoma multiforme. J Neurooncol. 2008 Nov; 90(2):229-35. Epub 2008 Jul 26.

Smith EL, Bakitas M, Meyer LP, Homel P, Fadul CE, Kingman LS, Schultz W, Skalla K, Bookbinder M. Using Quality Improvement Methodology to Improve Neuropathic Pain Screening and Assessment in Patients with Cancer. Journal of Cancer Education. In Press.

Mongan JP, Fadul CE, Cole BF, Zaki BI, Suriawinata AA, Ripple GH, Pipas JM. Brain metastases from Colorectal Cancer: Risk factors, incidence and the possible role of chemokines. Clinical Colorectal Cancer. In Press.

Mailing Address:
Norris Cotton Cancer Center
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756